User login
AGA members participated in the Alliance of Specialty Medicine’s annual legislative conference July 13-15, during which they met with legislators on Capitol Hill to advocate on behalf of specialty physicians and patients. They also heard from several members of Congress and agency officials.
During the conference, Dr. Joel V. Brill, AGAF, Dr. Michael Kochman, AGAF, Dr. Peter Margolis, AGAF, and Dr. Sarah Streett, thanked Congress for passing legislation to repeal the Sustainable Growth Rate. However, they urged legislators to continue to oversee the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) to ensure that the quality reporting programs are meaningful to specialty physicians and actually improve patient outcomes. In particular, changes need to be made to the Stage 3 meaningful use program to include measures that are appropriate for specialty physicians and their patients, and not implement a one-size fits all approach.
During their meeting with Sen. Bill Cassidy, R-La., a hepatologist and member of the Senate Health, Education, Labor and Pensions Committee, AGA leaders discussed alternative payment models that AGA is working on for common GI conditions, as well as how the AGA Center for GI Technology and Innovation (http://www.gastro.org/about/initiatives/aga-center-for-gi-innovation-technology) has designed observation research registries to help generate true comparative effectiveness research for new GI devices.
Sen. Cassidy said he is supportive of the role that observation research registries can play in determining the effectiveness of new treatments and technologies, as well as alternative payment models and ensuring that small practices are able to access and implement these types of models.
AGA and the alliance continue to advocate for sound health care policy that ensures patient access to specialty care.
AGA members participated in the Alliance of Specialty Medicine’s annual legislative conference July 13-15, during which they met with legislators on Capitol Hill to advocate on behalf of specialty physicians and patients. They also heard from several members of Congress and agency officials.
During the conference, Dr. Joel V. Brill, AGAF, Dr. Michael Kochman, AGAF, Dr. Peter Margolis, AGAF, and Dr. Sarah Streett, thanked Congress for passing legislation to repeal the Sustainable Growth Rate. However, they urged legislators to continue to oversee the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) to ensure that the quality reporting programs are meaningful to specialty physicians and actually improve patient outcomes. In particular, changes need to be made to the Stage 3 meaningful use program to include measures that are appropriate for specialty physicians and their patients, and not implement a one-size fits all approach.
During their meeting with Sen. Bill Cassidy, R-La., a hepatologist and member of the Senate Health, Education, Labor and Pensions Committee, AGA leaders discussed alternative payment models that AGA is working on for common GI conditions, as well as how the AGA Center for GI Technology and Innovation (http://www.gastro.org/about/initiatives/aga-center-for-gi-innovation-technology) has designed observation research registries to help generate true comparative effectiveness research for new GI devices.
Sen. Cassidy said he is supportive of the role that observation research registries can play in determining the effectiveness of new treatments and technologies, as well as alternative payment models and ensuring that small practices are able to access and implement these types of models.
AGA and the alliance continue to advocate for sound health care policy that ensures patient access to specialty care.
AGA members participated in the Alliance of Specialty Medicine’s annual legislative conference July 13-15, during which they met with legislators on Capitol Hill to advocate on behalf of specialty physicians and patients. They also heard from several members of Congress and agency officials.
During the conference, Dr. Joel V. Brill, AGAF, Dr. Michael Kochman, AGAF, Dr. Peter Margolis, AGAF, and Dr. Sarah Streett, thanked Congress for passing legislation to repeal the Sustainable Growth Rate. However, they urged legislators to continue to oversee the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) to ensure that the quality reporting programs are meaningful to specialty physicians and actually improve patient outcomes. In particular, changes need to be made to the Stage 3 meaningful use program to include measures that are appropriate for specialty physicians and their patients, and not implement a one-size fits all approach.
During their meeting with Sen. Bill Cassidy, R-La., a hepatologist and member of the Senate Health, Education, Labor and Pensions Committee, AGA leaders discussed alternative payment models that AGA is working on for common GI conditions, as well as how the AGA Center for GI Technology and Innovation (http://www.gastro.org/about/initiatives/aga-center-for-gi-innovation-technology) has designed observation research registries to help generate true comparative effectiveness research for new GI devices.
Sen. Cassidy said he is supportive of the role that observation research registries can play in determining the effectiveness of new treatments and technologies, as well as alternative payment models and ensuring that small practices are able to access and implement these types of models.
AGA and the alliance continue to advocate for sound health care policy that ensures patient access to specialty care.
